Home › NDC Lookup › RxCUI directory › RxCUI 285016

Dofetilide 0.5 MG Oral Capsule [Tikosyn] — RxCUI 285016

RxNorm drug concept · Semantic branded drug
RxCUI 285016 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI285016
Official nameDofetilide 0.5 MG Oral Capsule [Tikosyn]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asTikosyn 0.5 MG Oral Capsule; Tikosyn 500 MCG Oral Capsule
FDA products mapped3
Package NDCs mapped6
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dofetilide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Dofetilide can cause a serious, potentially life-threatening heart rhythm problem called Torsade de Pointes, especially in the first few days of treatment. The hospital stay — at l...
  • Why do I have to stay in the hospital just to start this pill?
  • You need to check before taking anything new — even over-the-counter medications. For example, cimetidine (a common heartburn drug found in some antacids) is completely off-limits...
  • Can I take my usual heartburn or allergy medicine while on dofetilide?
📖 Read our full Dofetilide guide →

🕸️ Concept Web — How Dofetilide 0.5 MG Oral Capsule [Tikosyn] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Dofetilide 0.5 MG Oral Capsule [Tikosyn] RxCUI 285016

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Dofetilide 49247
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Tikosyn 261672
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dofetilide Oral Capsule 374623
    • Dofetilide Oral Product 1160620
    • Dofetilide Pill 1160621
    • Dofetilide Oral Capsule [Tikosyn] 366556
    • Tikosyn Oral Product 1178508
    • Tikosyn Pill 1178509
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Dofetilide 0.5 MG Oral Capsule SCD · 310005
  • Dofetilide 0.5 MG SCDC · 330325
  • Dofetilide Oral Capsule SCDF · 374623
  • Dofetilide Oral Product SCDG · 1160620
  • Dofetilide Pill SCDG · 1160621

Brand-Name Concepts

  • Dofetilide 0.5 MG [Tikosyn] SBDC · 575066
  • Dofetilide Oral Capsule [Tikosyn] SBDF · 366556
  • Tikosyn Oral Product SBDG · 1178508
  • Tikosyn Pill SBDG · 1178509
  • Tikosyn BN · 261672

📦 FDA Products & Package NDCs

3 products · 6 package NDCs
6 package NDCs map to RxCUI 285016 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00069-5800-60 60 CAPSULE in 1 BOTTLE (0069-5800-60) Tikosyn Pfizer Laboratories Div Pfizer Inc 1999-10-01
00069-5800-61 14 CAPSULE in 1 BOTTLE (0069-5800-61) Tikosyn Pfizer Laboratories Div Pfizer Inc 1999-10-01
00069-5810-60 60 CAPSULE in 1 BOTTLE (0069-5810-60) Tikosyn Pfizer Laboratories Div Pfizer Inc 1999-10-01
00069-5810-61 14 CAPSULE in 1 BOTTLE (0069-5810-61) Tikosyn Pfizer Laboratories Div Pfizer Inc 1999-10-01
00069-5820-60 60 CAPSULE in 1 BOTTLE (0069-5820-60) Tikosyn Pfizer Laboratories Div Pfizer Inc 1999-10-01
00069-5820-61 14 CAPSULE in 1 BOTTLE (0069-5820-61) Tikosyn Pfizer Laboratories Div Pfizer Inc 1999-10-01
Observed labelers: Pfizer Laboratories Div Pfizer Inc (6) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.